Talking With Docs on MSN

Irregular heartbeat explained by doctors: what's harmless and what's not

Irregular heartbeat explained by doctors: what's harmless and what's not ...
ainvest

Xvivo Perfusion Is an Excellent Business — Priced for a Heart Launch Still Years Away

Xvivo Perfusion reported 34% revenue growth and 21% EBITDA margin in Q3 2026, with European CE approval and U.S.